SNAP Trial

SNAP-GWAS: An integrate precision medicine platform to predict antibiotic treatment outcomes in SNAP

We are inviting you to participate in this substudy because you have joined the SNAP platform.

‍

A large amount of variation exists within the genome of pathogenic Staphylococcus aureus that can be observed between regions or even individuals. These genetic differences can affect how the pathogen interacts with the host and administered treatments.
‍
These genetic differences could affect the optimal treatment regimen for any one individual with a Staphylococcus aureus bloodstream infection.
‍
This study aims to use a computational approach to compare the genomes of different strains of S. aureus pathogens to identify markers that can be used to steer clinicians' decisions to the best possible treatment option at a targeted, individual level.

This study is being conducted worldwide using bacterial isolates collected from all sites.

Lead Investigator: Dr. Stefano Giulieri - University of Melbourne, The Peter Doherty Institute for Infection and Immunity.

Email: stefano.giulieri@unimelb.edu.au

What will the sub study involve - more information

Please read the below information to learn more about the assessments and tests involved in this sub-study:

Bacterial isolates: Baseline bloodstream isolates from persistent bactaraemia (5 days or longer) or recurrent infections within 90 days of enrolment will be collected.

We will use these isolates to perform whole genome sequencing and high-throughput antibiotic susceptibility testing.

Risks and benefits of taking part in this sub study

Risks:

There are no potential risks or adverse events that are expected to occur during this substudy

Benefits:

Data from this substudy will benefit the wider population of individuals affected with Staphylococcus aureus bloodstream infections.
Clinicians will be better informed to make decisions that optimizes the treatment of S. aureus bloodstream infections, potentially reducing treatment time, cost, and minimizing any adverse effects as a result of treatment.

Where will my information be collected and stored?

Your information will be kept strictly confidential
Bacterial isolates should already be available as they are collected as part of the core SNAP trial protocol

What if I withdraw from the substudy?

You can withdraw from the sub study and/or from future use of your samples at any time, just notify a member of the SNAP study team.

If you withdraw, we will keep any information we have collected about you up until you withdraw. If you do not agree with this, you should not join this substudy.

‍